Real‐time impact of COVID‐19 pandemic on cutaneous leishmaniasis case finding and strategic planning, preventive interventions, control and epidemiology in a region with a high burden of cutaneous leishmaniasis and COVID‐19: A cross‐sectional descriptive study based on registry data in Ilam‐Iran

Abstract

Background and AimsCutaneous leishmaniasis (CL) is a severe parasitic disease affecting people, mostly in underdeveloped nations. As a zoonotic infection yearly incidence of CL depends on several parameters such as demographic, epidemiological, and environmental factors as well as prevention and control measures. The sudden outbreak of pandemics such as SARS‐Corona‐Virus‐2 pandemic, can probably affect the incidence or reporting of other diseases, especially infectious diseases, in various ways such as pressure on health systems, providing sanitary services and its components, lockdowns and changes in people's living habits.AimThis study aimed to evaluate the COVID‐19 impact on the incidence and other epidemiological aspects as well as control measures of CL in Ilam Province‐Iran.MethodsRequired data was extracted from the CL registration system in Ilam from 2014 to 2021 to demonstrate the trend of CL incidence before and after COVID‐19 pandemic.ResultsBased on our results, a declining pattern of CL incidence was observed, accompanied by the advent and intensification of the viral pandemic in Iran and Ilam province. Although, this decreasing pattern was not integral in all areas, and even increase in CL detection was emphasized in some regions.ConclusionIt may be inferred that the COVID‐19 pandemic may disrupt treatment programs of CL cases, rodent nest destruction, and fighting vector insects.

Effect of Rodent Control Program on Incidence of Zoonotic Cutaneous Leishmaniasis, Iran

“…In Brazil, the COVID-19 pandemic seems to have contributed to an increase in the incidence of tegumentary leishmaniasis in 2020 ( 10 ). A decreasing incidence of CL was reported in an endemic region in western Iran during the COVID-19 pandemic (2020–2021), possibly because of the disruption of CL diagnosis and treatment follow-up ( 11 ).…”